Get the Stockscreener App
12.00
0.17%
-0.02
Abrdn Life Sciences Investors stock is traded at $12.00, with a volume of 91,999.
It is down -0.17% in the last 24 hours and up +4.80% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$12.02
Open:
$12.1
24h Volume:
91,999
Relative Volume:
0.72
Market Cap:
$365.08M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-7.76%
1M Performance:
+4.80%
6M Performance:
-21.16%
1Y Performance:
-13.17%
1-Day Range:
$11.98
$12.18
1-Week Range:
$11.88
$13.09
52-Week Range:
$10.55
$15.90
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
12.00 | 365.08M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
9.63 | 3.55B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
33.66 | 2.93B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
25.59 | 2.46B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
19.27 | 2.27B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
14.25 | 2.24B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Grows By 46.5% - MarketBeat
AQR Arbitrage LLC Has $2.47 Million Stake in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 26.2% in April - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Shares Sold by AQR Arbitrage LLC - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Stock Position Increased by Invesco Ltd. - Defense World
Raymond James Financial Inc. Invests $3.13 Million in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Shares Sold by Quarry LP - MarketBeat
Quarry LP Lowers Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount - Yahoo
Walleye Capital LLC Invests $477,000 in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update - ACCESS Newswire
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Increases By 26.3% - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 9,144 Shares - MarketBeat
937,656 Shares in Abrdn Healthcare Investors (NYSE:HQH) Purchased by Raymond James Financial Inc. - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Down 26.0% in March - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Shares Sold by 1607 Capital Partners LLC - MarketBeat
Abrdn Healthcare Opportunities Fund (NYSE:THQ) Short Interest Update - Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells $179,718.00 in Stock - MarketBeat
Saba Capital Management, L.P. Sells 30,156 Shares of Abrdn Life Sciences Investors (NYSE:HQL) Stock - MarketBeat
Short Interest in Abrdn Healthcare Investors (NYSE:HQH) Declines By 26.0% - Defense World
Saba capital management sells $179,718 in Abrdn life sciences stock - Investing.com Australia
Series CGlycomine - Crunchbase
Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG - Business Wire
LPL Financial LLC Has $3.77 Million Holdings in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock - Investing.com Australia
Wilson Sonsini Advises Glycomine on $115 Million Series C - Wilson Sonsini
Saba capital management sells $179,718 in Abrdn life sciences stock By Investing.com - Investing.com South Africa
LPL Financial LLC Raises Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock By Investing.com - Investing.com South Africa
Abrdn Healthcare Investors (NYSE:HQH) Reaches New 1-Year LowTime to Sell? - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 6,889 Shares - MarketBeat
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.36%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):